Coexistent rheumatoid arthritis and hyperuricemia: clinical and immunological features

Abstract

BACKGROUND: Currently, the negative role of asymptomatic hyperuricemia (HU) in the development and progression of cardiovascular pathology, metabolic disorders and chronic kidney disease is generally recognized. There is not much data in the literature on the effect of HU on the course of rheumatoid arthritis (RA), therefore, the study of the relationship of HU with clinical, radiological and immunological features of RA seems relevant.

AIM: To study the relationship between HU with the clinical, radiological and immunological features of RA.

MATERIALS AND METHODS: The data of 262 patients with RA and HU and 262 with RA without HU (comparison group) included in the city register from January 2000 to April 2020 have been analyzed. The information included demographic features (gender, age), diagnosis, presence and duration of HU, duration of observation, disease activity, laboratory, immunological, radiological and functional parameters, therapy of the underlying disease. HU was understood as a recorded ≥1-fold increase in the level of uric acid (UA) in the blood serum >360 mmol/l. The study has been approved by the local ethics committee.

RESULTS: The data of 524 patients with rheumatoid arthritis for the period from January 2000 to April 2020 have been analyzed. The study included 440 women and 84 men. The average age of the patients was 60.0 ± 13.6 y. The patients with HU have been divided into two subgroups: the first – with the level of UA less than 500 mmol/l, the second — with the level of UA more than 500 mmol/l. The number of males was significantly higher among the patients with high HU than among the patients with low HU and the comparison group. Every third patient had significant structural changes in the joints (radiological stage III-IV) and 98% of the patients had moderate and pronounced functional limitations (functional class 2-3). The patients with HU were older, had more follow-up visits, were observed for a longer period of time, had a lower frequency of radiological progression, a greater number of painful and swollen joints, less often and at a smaller dose had methotrexate and more often sulfasalazine in comparison with the patients without HU (p < 0.05).

CONCLUSIONS: 1) Thus, we can emphasize the negative impact of hyperuricemia on the course of rheumatoid arthritis: if it is present, there are direct (more PJ, SJ) and indirect signs of a more severe course (longer duration of observation and the number of visits). 2) Immunosuppressive therapy is associated with the absence of differences with the generally recognized markers of disease activity (ESR, CRP, DAS28), the immunological profile (RF, ACCP) and the ambiguous relationship with radiological progression and functional insufficiency of the joints, as well as unreliable relationship with a higher frequency of bone density reduction.

Keywords

rheumatoid arthritis / hyperuricemia / uric acid / methotrexate / leflunomide

References

[1] Lussier A de Medicis R, Marquis L, Menard H. Inhibition of adjuvant-induced arthritis in the hyperuricemic rat. Agents Actions. 1978;8(5):536–542. DOI: 10.1007/BF02111442

[2] Lussier A., de Medicis R., Marquis L., Menard H. Inhibition of adjuvant-induced arthritis in the hyperuricemic rat // Agents Actions. 1978. Vol. 8, No. 5. P. 536–542. DOI: 10.1007/BF02111442

[3] A Lussier de Medicis R, Tetreault L. Effect of a high serum uric acid diet and injections of urate crystals on adjuvant arthritis in the rat. Rev Rhum Mal Osteoartic. 1980;47(6):393–398. (In French)

[4] Lussier A., de Medicis R., Tetreault L. Effect of a high serum uric acid diet and injections of urate crystals on adjuvant arthritis in the rat // Rev. Rhum. Mal. Osteoartic. 1980. Vol. 47, No. 6. P. 393–398. (In French)

[5] Chang YH, Bluestone RYH. Adjuvant polyarthritis. VI. Effect of oxonate-induced hyperuricemia on the development of acute inflammation, immune response and adjuvant arthritis. J Pharmacol Exp Ther. 1981;219(3):731–734.

[6] Chang Y.H., Bluestone R.Y.H. Adjuvant polyarthritis. VI. Effect of oxonate-induced hyperuricemia on the development of acute inflammation, immune response and adjuvant arthritis // J. Pharmacol. Exp. Ther. 1981. Vol. 219, No. 3. 731–734.

[7] Turner RA, Pisko EJ, Agudelo CA, et al. Uric acid effects on in vitro models of rheumatoid inflammatory and autoimmune processes. Ann Rheum Dis. 1983;42(3):338–342. DOI: 10.1136/ard.42.3.338

[8] Turner R.A., Pisko E.J., Agudelo C.A. et al. Uric acid effects on in vitro models of rheumatoid inflammatory and autoimmune processes // Ann. Rheum. Dis. 1983. Vol. 42, No. 3. P. 338–342. DOI: 10.1136/ard.42.3.338

[9] Situnayake RD, Thurnham DI, Kootathep S, et al. Chain breaking antioxidant status in rheumatoid arthritis: clinical and laboratory correlates. Ann Rheum Dis. 1991;50(2):81–86. DOI: 10.1136/ard.50.2.81

[10] Situnayake R.D., Thurnham D.I., Kootathep S. et al. Chain breaking antioxidant status in rheumatoid arthritis: clinical and laboratory correlates // Ann. Rheum. Dis. 1991. Vol. 50, No. 2. P. 81–86. DOI: 10.1136/ard.50.2.81

[11] Agudelo CA, Turner RA, Panetti M, Pisko E. Does hyperuricemia protect from rheumatoid inflammation? A clinical study. Arthritis Rheum. 1984;27(4):443–448. DOI: 10.1002/art.1780270412

[12] Agudelo C.A., Turner R.A., Panetti M., Pisko E. Does hyperuricemia protect from rheumatoid inflammation? A clinical study // Arthritis Rheum. 1984. Vol. 27, No. 4. P. 443–448. DOI: 10.1002/art.1780270412

[13] Pekhlivanov D, Khadzhiev SN. Correlation between blood levels of uric acid and calcium in rheumatoid arthritis and deforming polyosteoarthrosis. Revmatologiia (Mosk). 1989;(2):12–15.

[14] Pekhlivanov D., Khadzhiev S.N. Correlation between blood levels of uric acid and calcium in rheumatoid arthritis and deforming polyosteoarthrosis // Revmatologiia (Mosk). 1989. No. 2. P. 12–15.

[15] Mahajan M, Kaur S, Mahajan S, Kant R. Uric acid a better scavenger of free radicals than vitamin C in rheumatoid arthritis. Indian J Clin Biochem. 2009;24(2):205–207. DOI: 10.1007/s12291-009-0038-6

[16] Mahajan M., Kaur S., Mahajan S., Kant R. Uric acid a better scavenger of free radicals than vitamin C in rheumatoid arthritis // Indian J. Clin. Biochem. 2009. Vol. 24, No. 2. P. 205–207. DOI: 10.1007/s12291-009-0038-6

[17] Wang R, Huang W, Liang X. Involvement of mitogen-activated protein kinases and peroxisome proliferator-activated receptor γ in monosodium urate crystal-induced vascular cell adhesion molecule 1 expression in human rheumatoid arthritis synovial fibroblasts. Int J Mol Med. 2012;29(5):877–882. DOI: 10.3892/ijmm.2012.925

[18] Wang R., Huang W., Liang X. Involvement of mitogen-activated protein kinases and peroxisome proliferator-activated receptor γ in monosodium urate crystal-induced vascular cell adhesion molecule 1 expression in human rheumatoid arthritis synovial fibroblasts // Int. J. Mol. Med. 2012. Vol. 29, No. 5. P. 877–882. DOI: 10.3892/ijmm.2012.925

[19] Di Giovine FS, Malawista SE, Thornton E, Duff GW. Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest. 1991;87(4):1375–1381. DOI: 10.1172/JCI115142

[20] Di Giovine F.S., Malawista S.E., Thornton E., Duff G.W. Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution // J. Clin. Invest. 1991. Vol. 87, No. 4. P. 1375–1381. DOI: 10.1172/JCI115142

[21] Magnus JH, Shankar A, Broussard DL. Self-report of depressive symptoms in African American and white women in primary care. J Natl Med Assoc. 2010;102(5):389–395. DOI: 10.1016/s0027-9684(15)30573-3

[22] Magnus J.H., Shankar A., Broussard D.L. Self-report of depressive symptoms in African American and white women in primary care // J. Natl. Med. Assoc. 2010. Vol. 102, No. 5. P. 389–395. DOI: 10.1016/s0027-9684(15)30573-3

[23] Mohammed Ali DM, Al-Fadhel SZ, Al-Ghuraibawi NHA, Al-Hakeim HK. Serum chemerin and visfatin levels and their ratio as possible diagnostic parameters of rheumatoid arthritis. Reumatologia. 2020;58(2):67–75. DOI: 10.5114/reum.2020.95359

[24] Mohammed Ali D.M., Al-Fadhel S.Z., Al-Ghuraibawi N.H.A., Al-Hakeim H.K. Serum chemerin and visfatin levels and their ratio as possible diagnostic parameters of rheumatoid arthritis // Reumatologia. 2020. Vol. 58, No. 2. P. 67–75. DOI: 10.5114/reum.2020.95359

[25] Chiou A, England BR, Sayles H, et al. Coexistent hyperuricemia and gout in rheumatoid arthritis: associations with comorbidities, disease activity, and mortality. Arthritis Care Res (Hoboken). 2020;72(7):950–958. DOI: 10.1002/acr.23926

[26] Chiou A., England B.R., Sayles H. et al. Coexistent hyperuricemia and gout in rheumatoid arthritis: associations with comorbidities, disease activity, and mortality // Arthritis Care Res. (Hoboken). 2020. Vol. 72, No. 7. P. 950–958. DOI: 10.1002/acr.23926

[27] Weaver WF, Smyth CJ. Serum urate in degenerative joint disease and rheumatoid arthritis. Arthritis Rheum. 1963;6:372–376. DOI: 10.1002/art.1780060408

[28] Weaver W.F., Smyth C.J. Serum urate in degenerative joint disease and rheumatoid arthritis // Arthritis Rheum. 1963. Vol. 6. P. 372–376. DOI: 10.1002/art.1780060408

[29] Lambert JR, Wright V. Serum uric acid levels in psoriatic arthritis. Ann Rheum Dis. 1977;36(3):264–267. DOI: 10.1136/ard.36.3.264

[30] Lambert J.R., Wright V. Serum uric acid levels in psoriatic arthritis // Ann. Rheum. Dis. 1977. Vol. 36, No. 3. P. 264–267. DOI: 10.1136/ard.36.3.264

[31] Ren J, Zhou Y, Wu H, et al. Value of dual-energy computed tomography in the diagnosis of gouty arthritis. Nan Fang Yi Ke Da Xue Xue Bao. 2015;35(3):384–386. (In Chinese)

[32] Ren J., Zhou Y., Wu H. et al. Value of dual-energy computed tomography in the diagnosis of gouty arthritis // Nan. Fang. Yi. Ke. Da. Xue. Xue. Bao. 2015. Vol. 35, No. 3. P. 384–386. (In Chinese)

[33] Petsch C, Araujo EG, Englbrecht M, et al. Prevalence of monosodium urate deposits in a population of rheumatoid arthritis patients with hyperuricemia. Semin Arthritis Rheum. 2016;45(6):663–668. DOI: 10.1016/j.semarthrit.2015.11.014

[34] Petsch C., Araujo E.G., Englbrecht M. et al. Prevalence of monosodium urate deposits in a population of rheumatoid arthritis patients with hyperuricemia // Semin. Arthritis Rheum. 2016. Vol. 45, No. 6. P. 663–668. DOI: 10.1016/j.semarthrit.2015.11.014

[35] Mazurov VI, Bashkirov RA, Fonturenko AYu, et al. Features of the course of rheumatoid arthritis and osteoarthritis in patients with asymptomatic hyperuricemia. Herald of North-Western State Medical University named after I.I. Mechnikov. 2020;12(3):63–72. (In Russ). DOI: 10.17816/mechnikov44234

[36] Мазуров В.И., Башкинов Р.А., Фонтуренко А.Ю. и др. Особенности течения ревматоидного артрита и остеоартрита у пациентов с бессимптомной гиперурикемией // Вестник Северо-Западного государственного медицинского университета им. И.И. Мечникова. 2020. Т. 12, № 3. С. 63–72. DOI: 10.17816/mechnikov44234

[37] Luczak A, Knevel R, Huizinga TW, et al. No impact of serum uric acid on the outcome of recent-onset arthritis. Ann Rheum Dis. 2012;71(8):1424–1425. DOI: 10.1136/annrheumdis-2011-201027

[38] Luczak A., Knevel R., Huizinga T.W. et al. No impact of serum uric acid on the outcome of recent-onset arthritis // Ann. Rheum. Dis. 2012. Vol. 71, No. 8. P. 1424–1425. DOI: 10.1136/annrheumdis-2011-201027

[39] Hu Z, Xu S, Lin H, et al. Prevalence and risk factors for bone loss in Southern Chinese with rheumatic diseases. BMC Musculoskelet Disord. 2020;21(1):416. DOI: 10.1186/s12891-020-03403-1

[40] Hu Z., Xu S., Lin H. et al. Prevalence and risk factors for bone loss in Southern Chinese with rheumatic diseases // BMC Musculoskelet. Disord. 2020. Vol. 21, No. 1. P. 416. DOI: 10.1186/s12891-020-03403-1

[41] Lee HN, Kim A, Kim Y, et al. Higher serum uric acid levels are associated with reduced risk of hip osteoporosis in postmenopausal women with rheumatoid arthritis. Medicine (Baltimore). 2020;99(24):e20633. DOI: 10.1097/MD.0000000000020633

[42] Lee H.N., Kim A., Kim Y. et al. Higher serum uric acid levels are associated with reduced risk of hip osteoporosis in postmenopausal women with rheumatoid arthritis // Medicine (Baltimore). 2020. Vol. 99, No. 24. P. e20633. DOI: 10.1097/MD.0000000000020633

[43] Perez-Ruiz F, Nolla JM, et al. Influence of leflunomide on renal handling of urate and phosphate in patients with rheumatoid arthritis. J Clin Rheumatol. 2003;9(4):215–218. DOI: 10.1097/01.rhu.0000081470.31167.8b

[44] Perez-Ruiz F., Nolla J.M. Influence of leflunomide on renal handling of urate and phosphate in patients with rheumatoid arthritis // J. Clin. Rheumatol. 2003. Vol. 9, No. 4. P. 215–218. DOI: 10.1097/01.rhu.0000081470.31167.8b

[45] Costa NT, Scavuzzi BM, Iriyoda TMV, et al. Metabolic syndrome and the decreased levels of uric acid by leflunomide favor redox imbalance in patients with rheumatoid arthritis. Clin Exp Med. 2018;18(3):363–372. DOI: 10.1007/s10238-018-0500-y

[46] Costa N.T., Scavuzzi B.M., Iriyoda T.M.V. et al. Metabolic syndrome and the decreased levels of uric acid by leflunomide favor redox imbalance in patients with rheumatoid arthritis // Clin. Exp. Med. 2018. Vol. 18, No. 3. P. 363–372. DOI: 10.1007/s10238-018-0500-y

[47] Choe JY, Kim SK. Association between serum uric acid and inflammation in rheumatoid arthritis: perspective on lowering serum uric acid of leflunomide. Clin Chim Acta. 2015;438:29–34. DOI: 10.1016/j.cca.2014.07.039

[48] Choe J.Y., Kim S.K. Association between serum uric acid and inflammation in rheumatoid arthritis: perspective on lowering serum uric acid of leflunomide // Clin. Chim. Acta. 2015. Vol. 438. P. 29–34. DOI: 10.1016/j.cca.2014.07.039

[49] Gosselt HR, Muller IB, Jansen G, et al. Identification of metabolic biomarkers in relation to methotrexate response in early rheumatoid arthritis. J Pers Med. 2020;10(4):271. DOI: 10.3390/jpm10040271

[50] Gosselt H.R., Muller I.B., Jansen G. et al. Identification of metabolic biomarkers in relation to methotrexate response in early rheumatoid arthritis // J. Pers. Med. 2020. Vol. 10, No. 4. P. 271. DOI: 10.3390/jpm10040271

[51] Smoleńska Z, Kaznowska Z, Zarówny D, et al. Effect of methotrexate on blood purine and pyrimidine levels in patients with rheumatoid arthritis. Rheumatology (Oxford). 1999;38(10):997–1002. DOI: 10.1093/rheumatology/38.10.997

[52] Smoleńska Z., Kaznowska Z., Zarówny D. et al. Effect of methotrexate on blood purine and pyrimidine levels in patients with rheumatoid arthritis // Rheumatology (Oxford). 1999. Vol. 38, No. 10. P. 997–1002. DOI: 10.1093/rheumatology/38.10.997

[53] Lee J.J., Bykerk VP, Dresser GK, et al. Reduction in serum uric acid may be related to methotrexate efficacy in early rheumatoid arthritis: data from the Canadian Early Arthritis Cohort (CATCH). Clin Med Insights Arthritis Musculoskelet Disord. 2016;9:37–43. DOI: 10.4137/CMAMD.S38092

[54] Lee J.J., Bykerk V.P., Dresser G.K. et al. Reduction in serum uric acid may be related to methotrexate efficacy in early rheumatoid arthritis: data from the Canadian Early Arthritis Cohort (CATCH) // Clin. Med. Insights Arthritis Musculoskelet. Disord. 2016. Vol. 9. P. 37–43. DOI: 10.4137/CMAMD.S38092

[55] Bilecik NA, Tuna S, Samancı N, et al. Prevalence of metabolic syndrome in women with rheumatoid arthritis and effective factors. Int J Clin Exp Med. 2014;7(8):2258–2265.

[56] Bilecik N.A., Tuna S., Samancı N. et al. Prevalence of metabolic syndrome in women with rheumatoid arthritis and effective factors // Int. J. Clin. Exp. Med. 2014. Vol. 7, No. 8. P. 2258–2265.

[57] Chen Z, Tu S, Hu Y, et al. Prediction of response of collagen-induced arthritis rats to methotrexate: an (1)H-NMR-based urine metabolomic analysis. J Huazhong Univ Sci Technolog Med Sci. 2012;32(3):438–443. DOI: 10.1007/s11596-012-0076-9

[58] Chen Z., Tu S., Hu Y. et al. Prediction of response of collagen-induced arthritis rats to methotrexate: an (1)H-NMR-based urine metabolomic analysis // J. Huazhong. Univ. Sci. Technolog. Med. Sci. 2012. Vol. 32, No. 3. P. 438–443. DOI: 10.1007/s11596-012-0076-9

[59] Araiza-Casillas R, Díaz-Molina R, González-Ortiz M, Robinson-Navarro OM. Effects of hydroxychloroquine on insulin sensitivity and lipid profile in patients with rheumatoid arthritis. Rev Med Chil. 2013;141(8):1019–1025. (In Spanish). DOI: 10.4067/S0034-98872013000800008

[60] Araiza-Casillas R., Díaz-Molina R., González-Ortiz M., Robinson-Navarro O.M. Effects of hydroxychloroquine on insulin sensitivity and lipid profile in patients with rheumatoid arthritis // Rev. Med. Chil. 2013. Vol. 141, No. 8. P. 1019–1025. (In Spanish). DOI: 10.4067/S0034-98872013000800008

RIGHTS & PERMISSIONS

Mazurov V.I., Gaydukova I.Z., Fonturenko A.Y., Bashkinov R.A., Petrova M.S., Inamova O.V.